387 related articles for article (PubMed ID: 31918224)
1. Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway.
Ni R; Song G; Fu X; Song R; Li L; Pu W; Gao J; Hu J; Liu Q; He F; Zhang D; Huang G
Biomaterials; 2020 Feb; 232():119730. PubMed ID: 31918224
[TBL] [Abstract][Full Text] [Related]
2. ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis
Song Y; Ismail M; Shan Q; Zhao J; Zhu Y; Zhang L; Du Y; Ling L
Nanoscale; 2021 Dec; 13(47):20170-20185. PubMed ID: 34846489
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-loaded pH/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-κB signaling pathway.
Lu Y; Zhou J; Wang Q; Cai J; Yu B; Dai Q; Bao Y; Chen R; Zhang Z; Zhang D; Hou T
Acta Biomater; 2023 Jul; 164():458-473. PubMed ID: 37072065
[TBL] [Abstract][Full Text] [Related]
4. Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment.
Wang Y; Wang Q; Feng W; Yuan Q; Qi X; Chen S; Yao P; Dai Q; Xia P; Zhang D; Sun F
Drug Deliv; 2021 Dec; 28(1):1695-1708. PubMed ID: 34402706
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles.
Wang Y; Yuan Q; Feng W; Pu W; Ding J; Zhang H; Li X; Yang B; Dai Q; Cheng L; Wang J; Sun F; Zhang D
J Nanobiotechnology; 2019 Oct; 17(1):103. PubMed ID: 31581948
[TBL] [Abstract][Full Text] [Related]
6. Roxithromycin and rhEGF Co-loaded Reactive Oxygen Species Responsive Nanoparticles for Accelerating Wound Healing.
Ding J; Chen D; Hu J; Zhang D; Gou Y; Wu Y
Curr Drug Deliv; 2024; 21(5):753-762. PubMed ID: 37183469
[TBL] [Abstract][Full Text] [Related]
7. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization.
Li Y; Liang Q; Zhou L; Cao Y; Yang J; Li J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():406-424. PubMed ID: 36055613
[TBL] [Abstract][Full Text] [Related]
8. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
[TBL] [Abstract][Full Text] [Related]
9. Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy.
Zhao YP; Han JF; Zhang FY; Liao TT; Na R; Yuan XF; He GB; Ye W
Drug Deliv; 2022 Dec; 29(1):2269-2282. PubMed ID: 35815790
[TBL] [Abstract][Full Text] [Related]
10. ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment.
Muhammad W; Zhu J; Zhai Z; Xie J; Zhou J; Feng X; Feng B; Pan Q; Li S; Venkatesan R; Li P; Cao H; Gao C
Acta Biomater; 2022 Aug; 148():258-270. PubMed ID: 35724918
[TBL] [Abstract][Full Text] [Related]
11. Combined ROS Sensitive Folate Receptor Targeted Micellar Formulations of Curcumin Effective Against Rheumatoid Arthritis in Rat Model.
Wang Y; Guo R; Zou M; Jiang L; Kong L; Zhao S; Zhang X; Wang W; Xu B
Int J Nanomedicine; 2024; 19():4217-4234. PubMed ID: 38766660
[TBL] [Abstract][Full Text] [Related]
12. Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis.
Yan F; Zhong Z; Wang Y; Feng Y; Mei Z; Li H; Chen X; Cai L; Li C
J Nanobiotechnology; 2020 Aug; 18(1):115. PubMed ID: 32819405
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis.
Lee ES; Sul JH; Shin JM; Shin S; Lee JA; Kim HK; Cho Y; Ko H; Son S; Lee J; Park S; Jo DG; Park JH
Acta Biomater; 2021 Jul; 128():462-473. PubMed ID: 33878476
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone inhibits BAFF expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Reyes LI; León F; González P; Rozas MF; Labarca C; Segovia A; Neira O; Naves R
Cytokine; 2008 May; 42(2):170-178. PubMed ID: 18316202
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
Wang Y; Wang Q; Wang X; Yao P; Dai Q; Qi X; Yang M; Zhang X; Huang R; Yang J; Wang Q; Xia P; Zhang D; Sun F
J Nanobiotechnology; 2023 Aug; 21(1):286. PubMed ID: 37608285
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis.
Wang Q; Jiang J; Chen W; Jiang H; Zhang Z; Sun X
J Control Release; 2016 May; 230():64-72. PubMed ID: 27057749
[TBL] [Abstract][Full Text] [Related]
17. Tea polyphenol carrier-enhanced dexamethasone nanomedicines for inflammation-targeted treatment of rheumatoid arthritis.
Yi Z; Ran Y; Chen X; Tong Q; Ma L; Tan Y; Ma X; Li X
J Mater Chem B; 2023 Dec; 11(48):11505-11518. PubMed ID: 38038124
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-based M1 macrophage targeting and environmental responsive drug releasing nanoparticle for enhanced treatment of rheumatoid arthritis.
Wang P; Zhang Y; Lei H; Yu J; Zhou Q; Shi X; Zhu Y; Zhang D; Zhang P; Wang K; Dong K; Xing J; Dong Y
Carbohydr Polym; 2023 Sep; 316():121018. PubMed ID: 37321721
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
[TBL] [Abstract][Full Text] [Related]
20. Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-κB pathway in collagen-induced arthritis rats.
Wang Q; Xu B; Fan K; Wu J; Wang T
Mol Cell Biochem; 2020 Oct; 473(1-2):63-76. PubMed ID: 32594339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
